According to the report by Expert Market Research (EMR), the Global Allergy Immunotherapy Market Share attained a value of USD 2.04 billion in 2022. Aided by the rising prevalence of allergic diseases and growing acceptance of immunotherapy as a preferred treatment, the market is anticipated to grow at a CAGR of 9.6% during the forecast period of 2023-2031 to attain a value of USD 4.67 billion by 2031.
Allergy immunotherapy, also known as desensitisation or hypo-sensitisation, is a medical intervention for allergies. It involves gradually exposing the body to allergens to retrain the immune system’s response, hence reducing symptoms. The therapy is effective for allergies caused by pollen, dust mites, insect venom, certain foods, and more. It’s a long-term treatment that can decrease symptoms for many years even after it’s discontinued.
The rising global prevalence of allergic diseases, such as allergic rhinitis, asthma, and food allergies, is the primary driver propelling the global allergy immunotherapy market growth. The growing awareness of the adverse impacts of untreated allergies on health and quality of life has resulted in a significant shift towards seeking effective treatment, hence the surge in demand for allergy immunotherapy.
Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/allergy-immunotherapy-market/requestsample
Moreover, the growing acceptance of immunotherapy as a preferred treatment for various types of allergies is fuelling the allergy immunotherapy market expansion. Immunotherapy is increasingly being recognised for its potential to alter the course of allergic diseases, not just manage symptoms, making it a popular choice among healthcare providers and patients alike.
Allergy immunotherapy finds widespread application in medical practice. It is used for treating a broad range of allergies, including allergic rhinitis, allergic asthma, food allergies, and venom allergies. Its efficacy in reducing symptoms and improving the quality of life makes it a valuable treatment option in allergology, thus increasing the allergy immunotherapy market demand.
In addition to the current applications, continuous research and development activities have broadened the prospects of allergy immunotherapy. The development of new products, like sublingual immunotherapy tablets and epicutaneous immunotherapy patches, has expanded treatment options, enhancing the convenience and safety of immunotherapy.
Furthermore, the growing interest in personalised medicine has led to further development in allergy immunotherapy market. The exploration into precision medicine and biomarkers in allergy and immunology promises to personalise immunotherapy, potentially enhancing its efficacy and safety.
Market Segmentation
The market can be divided based on treatment type, allergen type, treatment channel, distribution channel, and region.
Market Breakup by Treatment Type
- Subcutaneous Immunotherapy (SCIT)
- Specific Immunotherapy (SIT)
- Sublingual Immunotherapy (SLIT)
- Sublingual Drops
- Sublingual Tablets
Market Breakup by Allergen Type
- Pollen Allergies
- Grass Pollen
- Tree Pollen
- Weed Pollen
- Food Allergies
- Peanut Allergies
- Tree Nut Allergies
- Shellfish Allergies
- Fish Allergies
- Egg Allergies
- Milk Allergies
- Soy Allergies
- Wheat Allergies
- Others
- Dust Mite Allergies
- Mold Allergies
- Animal Dander Allergies
- Insect Venom Allergies
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global allergy immunotherapy companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- ALK-Abelló A/S
- Allergy Therapeutics
- Aimmune Therapeutics
- Stallergenes Greer
- Merck Group
- HAL Allergy Group
- DBV Technologies
- Biomay AG
- Anergis SA
- Circassia Pharmaceuticals
- Laboratorios LETI
- HollisterStier Allergy
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.